Company: HCTI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001213900-25-099128
Chunk: 8

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 8
---
 positions
held currently or at any time during the last five years and the experiences, qualifications, attributes or skills that caused the nominating
and corporate governance committee to determine that the person should serve as a director of the Company. In addition to the information
presented below regarding each such person’s specific experience, qualifications, attributes and skills that led the Board of Directors
and its nominating and corporate governance committee to the conclusion that he or she should serve as a director, we also believe that
each of our directors has a reputation for integrity, honesty and adherence to high ethical standards. Each of our directors has demonstrated
business acumen and an ability to exercise sound judgment, as well as a commitment of service to our company and our Board of Directors.
Finally, we value our directors’ experience in relevant areas of business management and on other boards of directors and board
committees.

<div align='center'>5</div>

Our corporate governance guidelines also dictate
that a majority of the Board of Directors be comprised of independent directors whom the Board of Directors has determined have no material
relationship with the Company and who are otherwise “independent” directors under the published listing requirements of the
Nasdaq Capital Market (“Nasdaq”). The Company has determined that, with the exception of Ms. Sujatha Ramesh, our Chief
Operating Officer and Director, all of our other directors qualify as “independent” directors

Dave Rosa. Mr. Rosa has served
as a member of our board of directors since August 2021. Since 2016, Mr. Rosa has been and currently is President and CEO of NeuroOne
Medical Technologies (NMTC: Nasdaq), a publicly traded company on the Nasdaq. He also serves on the boards of Biotricity (BTCY: OTC),
a publicly traded company on the Over the Counter (OTC) platform, where he currently serves as compensation committee chairman and Neuro
Event Labs, a privately held company in Finland, where he currently serves as Chairman of the Board. Mr. Rosa has over 25 years of experience
holding a variety of senior management roles representing several medical device markets. His recent experience includes developing early-stage
companies to commercialization and Nasdaq listing. Mr. Rosa holds a Master of Business Administration degree from Duquesne University
and Bachelor of Science degree in Commerce and Engineering from Drexel University. We believe that Mr. Dave is well qualified to serve
as chairman of the Board of Directors. With his entrepreneurial, leadership